Foley Represents Nestle Skin Care and Galderma Against Truinject in Successful Institution of Two Inter Partes Reviews of Patents for Injection Training System
17 November 2020
Foley & Lardner is representing Galderma S.A. and Nestle Skin Health, Inc. in two IPR’s at the PTAB, challenging Truinject Corp.’s patents on automated detection of performance characteristics in an injection training system (U.S. Patent Nos. 10,290,231 and 10,290,232) following a district court complaint filed by Truinject based on the patents. On November 17, 2020, the PTAB granted institution of both IPRs, IPR2020-00935 and -00937 on all challenged claims on the requested grounds. Galderma S.A., formerly a subsidiary of Nestlé, is a global pharmaceutical company specializing in dermatological treatments and skin care products. The Foley team includes George Beck, Stephen B. Maebius, Chase Brill, and Kiri Lee Sharon.
People
Related News
10 February 2025
Press Releases
Foley Announces Divya Reddy as First Chief Practice Officer to Further Enhance Client Service and Collaboration
Foley & Lardner LLP is pleased to announce the promotion of Divya Reddy to the newly created role of Chief Practice Officer (CPO) to further enhance the firm’s client service and promote greater integration across the firm’s legal departments.
03 February 2025
Press Releases
Foley Announces 2025 New Partner Class
Foley & Lardner LLP is pleased to announce the promotion of 17 lawyers to the firm’s partnership, effective February 1, 2025.
17 January 2025
Press Releases
Young Leaders Share Their Dreams for the Future at Foley’s Annual MLK Jr. Oratory Competition
The voices of tomorrow resonated with hope and inspiration today as elementary students from Dallas, Houston, and Chicago took the stage for the final rounds of Foley & Lardner LLP’s Annual MLK Jr. Oratory Competitions.